Collegium Pharmaceutical (COLL) Current Leases (2019 - 2026)

Collegium Pharmaceutical has reported Current Leases for 8 years, with the latest figure at $1.6 million in Q2 2026.

• On a quarterly basis, Current Leases rose 16.67% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $1.6 million, a 16.67% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 10.7% from the prior year.
• Current Leases was $1.6 million for Q2 2026 at Collegium Pharmaceutical, up from $1.4 million in the prior quarter.
• The five-year high for Current Leases was $1.6 million in Q2 2026, with the low at $963000.0 in Q3 2023.
• Average Current Leases over 5 years is $1.2 million, with a median of $1.2 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Current Leases jumped 57.07% in 2022, then retreated 19.82% in 2023.
• Over 5 years, Current Leases stood at $1.1 million in 2022, then retreated by 11.15% to $988000.0 in 2023, then rose by 28.64% to $1.3 million in 2024, then advanced by 10.7% to $1.4 million in 2025, then grew by 10.95% to $1.6 million in 2026.
• The last three Current Leases figures came in at $1.6 million (Q2 2026), $1.4 million (Q1 2026), and $1.4 million (Q4 2025), per Business Quant data.